Stonepine Capital Management, LLC 13D and 13G filings for IO Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:30 pm Sale |
2024-09-30 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 0 0.000% |
-3,641,345 (Position Closed) |
Filing |
| 2024-02-13 4:29 pm Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 3,641,345 5.400% |
-309,271 (-7.83%) |
Filing |
| 2023-08-16 4:15 pm Purchase |
2023-08-07 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 3,950,616 5.800% |
3,950,616 (New Position) |
Filing |